116 related articles for article (PubMed ID: 36442415)
1. Expression of SATB2, RUNX2, and SOX9 and possible osteoblastic and chondroblastic differentiation in chondroblastoma.
Toda Y; Yamamoto H; Iwasaki T; Ishihara S; Ito Y; Susuki Y; Kawaguchi K; Kinoshita I; Kiyozawa D; Yamada Y; Kohashi K; Kimura A; Fujiwara T; Setsu N; Endo M; Matsumoto Y; Nakashima Y; Mawatari M; Oda Y
Pathol Res Pract; 2023 Jan; 241():154239. PubMed ID: 36442415
[TBL] [Abstract][Full Text] [Related]
2. H3.3 K36M Mutation as a Clinical Diagnosis Method of Suspected Chondroblastoma Cases.
Mu H; Jiang Y; Xue L; Hua Y; Lin J; Cai Z
Orthop Surg; 2021 Apr; 13(2):616-622. PubMed ID: 33620145
[TBL] [Abstract][Full Text] [Related]
3. Chondroblastoma of foot bones; a clinicopathological study of 29 cases confirming the diagnostic utility of H3K36M and H3G34W antibodies at an uncommon site.
Tariq MU; Din NU; Qureshi MB; Park YK
Ann Diagn Pathol; 2023 Aug; 65():152135. PubMed ID: 37075609
[TBL] [Abstract][Full Text] [Related]
4. Glucose regulates tissue-specific chondro-osteogenic differentiation of human cartilage endplate stem cells via O-GlcNAcylation of Sox9 and Runx2.
Sun C; Lan W; Li B; Zuo R; Xing H; Liu M; Li J; Yao Y; Wu J; Tang Y; Liu H; Zhou Y
Stem Cell Res Ther; 2019 Nov; 10(1):357. PubMed ID: 31779679
[TBL] [Abstract][Full Text] [Related]
5. SOX9 and SATB2 immunohistochemistry cannot reliably distinguish between osteosarcoma and chondrosarcoma on biopsy material.
Sharma AE; Pytel P; Cipriani NA
Hum Pathol; 2022 Mar; 121():56-64. PubMed ID: 35016891
[TBL] [Abstract][Full Text] [Related]
6. Expression of master regulatory genes controlling skeletal development in benign cartilage and bone forming tumors.
Dancer JY; Henry SP; Bondaruk J; Lee S; Ayala AG; de Crombrugghe B; Czerniak B
Hum Pathol; 2010 Dec; 41(12):1788-93. PubMed ID: 21078438
[TBL] [Abstract][Full Text] [Related]
7. Chondroblastoma: An Update.
Chen W; DiFrancesco LM
Arch Pathol Lab Med; 2017 Jun; 141(6):867-871. PubMed ID: 28557595
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical analysis for Sox9 reveals the cartilaginous character of chondroblastoma and chondromyxoid fibroma of the bone.
Konishi E; Nakashima Y; Iwasa Y; Nakao R; Yanagisawa A
Hum Pathol; 2010 Feb; 41(2):208-13. PubMed ID: 19801163
[TBL] [Abstract][Full Text] [Related]
9. Chondroblastoma-like primary malignant giant cell tumor of the humerus - a case report.
Kinkor Z; Grossmann P; Špůrková Z; Věcková Z; Matějovský Z
Cesk Patol; 2019; 55(1):42-47. PubMed ID: 30939886
[TBL] [Abstract][Full Text] [Related]
10. Effects of a miR-31, Runx2, and Satb2 regulatory loop on the osteogenic differentiation of bone mesenchymal stem cells.
Deng Y; Wu S; Zhou H; Bi X; Wang Y; Hu Y; Gu P; Fan X
Stem Cells Dev; 2013 Aug; 22(16):2278-86. PubMed ID: 23517179
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemistry for histone H3G34W and H3K36M is highly specific for giant cell tumor of bone and chondroblastoma, respectively, in FNA and core needle biopsy.
Schaefer IM; Fletcher JA; Nielsen GP; Shih AR; Ferrone ML; Hornick JL; Qian X
Cancer Cytopathol; 2018 Aug; 126(8):552-566. PubMed ID: 29757500
[TBL] [Abstract][Full Text] [Related]
12. Histone H3K36M mutation and trimethylation patterns in chondroblastoma.
Lu C; Ramirez D; Hwang S; Jungbluth A; Frosina D; Ntiamoah P; Healey J; Zhu G; Chen W; Klein M; Hameed M
Histopathology; 2019 Jan; 74(2):291-299. PubMed ID: 30098026
[TBL] [Abstract][Full Text] [Related]
13. Regulators of skeletal development: a cluster analysis of 206 bone tumors reveals diagnostically useful markers.
Horvai AE; Roy R; Borys D; O'Donnell RJ
Mod Pathol; 2012 Nov; 25(11):1452-61. PubMed ID: 22766796
[TBL] [Abstract][Full Text] [Related]
14. Histomorphometric Analysis of Pre- and Post-Denosumab-Treated Giant Cell Tumor of Bone.
Ud Din N; Umer M; Park YK
Int J Surg Pathol; 2020 Dec; 28(8):859-867. PubMed ID: 32429739
[No Abstract] [Full Text] [Related]
15. Dental Follicle Cells Participate in Tooth Eruption via the RUNX2-MiR-31-SATB2 Loop.
Ge J; Guo S; Fu Y; Zhou P; Zhang P; Du Y; Li M; Cheng J; Jiang H
J Dent Res; 2015 Jul; 94(7):936-44. PubMed ID: 25818585
[TBL] [Abstract][Full Text] [Related]
16. Lentiviral-mediated expression of SATB2 promotes osteogenic differentiation of bone marrow stromal cells in vitro and in vivo.
Gong Y; Qian Y; Yang F; Wang H; Yu Y
Eur J Oral Sci; 2014 Jun; 122(3):190-7. PubMed ID: 24666017
[TBL] [Abstract][Full Text] [Related]
17. Roles of SATB2 in osteogenic differentiation and bone regeneration.
Zhang J; Tu Q; Grosschedl R; Kim MS; Griffin T; Drissi H; Yang P; Chen J
Tissue Eng Part A; 2011 Jul; 17(13-14):1767-76. PubMed ID: 21385070
[TBL] [Abstract][Full Text] [Related]
18. Decrease of MiR-31 induced by TNF-α inhibitor activates SATB2/RUNX2 pathway and promotes osteogenic differentiation in ethanol-induced osteonecrosis.
Yu L; Xu Y; Qu H; Yu Y; Li W; Zhao Y; Qiu G
J Cell Physiol; 2019 Apr; 234(4):4314-4326. PubMed ID: 30132874
[TBL] [Abstract][Full Text] [Related]
19. Epithelial and cartilaginous differentiation in clear cell chondrosarcoma.
Matsuura S; Ishii T; Endo M; Takahashi Y; Setsu N; Yamamoto H; Tamiya S; Iwamoto Y; Oda Y
Hum Pathol; 2013 Feb; 44(2):237-43. PubMed ID: 22944296
[TBL] [Abstract][Full Text] [Related]
20. Regulative Effect of Mir-205 on Osteogenic Differentiation of Bone Mesenchymal Stem Cells (BMSCs): Possible Role of SATB2/Runx2 and ERK/MAPK Pathway.
Hu N; Feng C; Jiang Y; Miao Q; Liu H
Int J Mol Sci; 2015 May; 16(5):10491-506. PubMed ID: 25961955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
